| Tissue-based map of the human proteome M Uhlén, L Fagerberg, BM Hallström, C Lindskog, P Oksvold, ... Science 347 (6220), 2015 | 6679 | 2015 |
| Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics L Fagerberg, BM Hallström, P Oksvold, C Kampf, D Djureinovic, ... Molecular & Cellular Proteomics 13 (2), 397-406, 2014 | 1905 | 2014 |
| The Human Gene FALL39 and Processing of the Cathelin Precursor to the Antibacterial Peptide LL‐37 in Granulocytes GH Gudmundsson, B Agerberth, J Odeberg, T Bergman, B Olsson, ... European journal of biochemistry 238 (2), 325-332, 1996 | 634 | 1996 |
| FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis B Agerberth, H Gunne, J Odeberg, P Kogner, HG Boman, ... Proceedings of the National Academy of Sciences 92 (1), 195-199, 1995 | 627 | 1995 |
| Management of rivaroxaban-or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort study A Majeed, A Ågren, M Holmström, M Bruzelius, R Chaireti, J Odeberg, ... Blood, The Journal of the American Society of Hematology 130 (15), 1706-1712, 2017 | 205 | 2017 |
| Serum matrix metalloproteinase‐3 concentration is influenced by MMP‐3− 1612 5A/6A promoter genotype and associated with myocardial infarction A Samnegård, A Silveira, P Lundman, S Boquist, J Odeberg, J Hulthe, ... Journal of internal medicine 258 (5), 411-419, 2005 | 152 | 2005 |
| Expression profiling of adrenocortical neoplasms suggests a molecular signature of malignancy D Velázquez-Fernández, C Laurell, J Geli, A Höög, J Odeberg, ... Surgery 138 (6), 1087-1094, 2005 | 142 | 2005 |
| In silico detection of sequence variations modifying transcriptional regulation MC Andersen, PG Engström, S Lithwick, D Arenillas, P Eriksson, ... PLoS Comput Biol 4 (1), e5, 2008 | 115 | 2008 |
| Pyrosequencing for detection of lamivudine-resistant hepatitis B virus A Lindström, J Odeberg, J Albert Journal of Clinical Microbiology 42 (10), 4788-4795, 2004 | 101 | 2004 |
| Gene expression signatures, pathways and networks in carotid atherosclerosis L Perisic, S Aldi, Y Sun, L Folkersen, A Razuvaev, J Roy, M Lengquist, ... Journal of internal medicine 279 (3), 293-308, 2016 | 93 | 2016 |
| Association of venous thromboembolism with hormonal contraception and thrombophilic genotypes A Bergendal, I Persson, J Odeberg, A Sundström, M Holmström, ... Obstetrics & Gynecology 124 (3), 600-609, 2014 | 91 | 2014 |
| Validation of a composite score for clinical severity of hemophilia S Schulman, A Eelde, M Holmström, G Ståhlberg, J Odeberg, M Blombäck Journal of Thrombosis and Haemostasis 6 (7), 1113-1121, 2008 | 89 | 2008 |
| A genome-wide transcriptomic analysis of protein-coding genes in human blood cells M Uhlen, MJ Karlsson, W Zhong, A Tebani, C Pou, J Mikes, ... Science 366 (6472), 2019 | 86 | 2019 |
| SNP typing by apyrase‐mediated allele‐specific primer extension on DNA microarrays D O’Meara, A Ahmadian, J Odeberg, J Lundeberg Nucleic acids research 30 (15), e75-e75, 2002 | 79 | 2002 |
| Profiling of atherosclerotic lesions by gene and tissue microarrays reveals PCSK6 as a novel protease in unstable carotid atherosclerosis L Perisic, E Hedin, A Razuvaev, M Lengquist, C Osterholm, L Folkersen, ... Arteriosclerosis, thrombosis, and vascular biology 33 (10), 2432-2443, 2013 | 74 | 2013 |
| A structural basis for LCMV immune evasion: subversion of H-2Db and H-2Kb presentation of gp33 revealed by comparative crystal structure analyses A Achour, J Michaëlsson, RA Harris, J Odeberg, P Grufman, JK Sandberg, ... Immunity 17 (6), 757-768, 2002 | 69 | 2002 |
| Both risk alleles for FcγRIIA and FcγRIIIA are susceptibility factors for SLE: a unifying hypothesis V Magnusson, B Johanneson, G Lima, J Odeberg, D Alarcon-Segovia, ... Genes & Immunity 5 (2), 130-137, 2004 | 68 | 2004 |
| Genotyping by apyrase-mediated allele-specific extension A Ahmadian, B Gharizadeh, D O’Meara, J Odeberg, J Lundeberg Nucleic acids research 29 (24), e121-e121, 2001 | 67 | 2001 |
| Genetic instability in the 9q22. 3 region is a late event in the development of squamous cell carcinoma A Ahmadian, ZP Ren, C Williams, F Pontén, J Odeberg, J Pontén, ... Oncogene 17 (14), 1837-1843, 1998 | 62 | 1998 |
| Alternative promoter usage of the membrane glycoprotein CD36 M Andersen, B Lenhard, C Whatling, P Eriksson, J Odeberg BMC molecular biology 7 (1), 1-14, 2006 | 57 | 2006 |
Mathias UhlénScience for Life Laboratory, KTH, StockholmVerified email at scilifelab.se
